Ginkgo for cognitive dysfunction

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Aug 2020: Trial registered, NCT04525144
  2. 26 Oct 2020: Trial started, NCT04525144

The trials

NCT04525144: EGb 761 in the Syndrome of MCI With Concomitant CVD

State
Under way
Phase
Phase 2
People
134 planned
Started
26 Oct 2020
Primary completion
Dec 2025
Arms
Tebonin Forte
Results
None posted
  1. 25 Aug 2020: Trial registered
  2. 26 Oct 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Tanakan, Tebonin Forte.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.